Bigul

Gufic Biosciences Ltd - 509079 - Clarification On Significant Movement In Price

With reference to your communication dated May 14, 2021, seeking clarification for movement in price, we hereby clarify that there is no pending information or announcement (including impending announcement) from the Company which in our opinion may have a bearing on the price / volume behaviour in the scrip. The movement in the shares price of the Company is purely due to market conditions and absolutely market driven and the Management of the Company is no way connected with any such price increase/volume increase. You are requested to kindly take the same on record.
18-05-2021
Bigul

Gufic Biosciences Ltd - 509079 - Clarification sought from Gufic Biosciences Ltd

The Exchange has sought clarification from Gufic Biosciences Ltd on May 14, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
14-05-2021
Bigul

Gufic Biosciences Ltd - 509079 - Format of the Annual Disclosure to be made by an entity identified as a Large Corporate

We would like to inform you that Gufic Biosciences Limited is not falling under category of "Large Corporate" as per the applicability criteria mentioned under the SEBI Circular No. SEBl/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large Corporates Kindly take the same on record.
26-04-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholding for the Period Ended March 31, 2021

Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
20-04-2021
Bigul

Gufic Biosciences Ltd - 509079 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended March 31, 2021

Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Manish Ghia & Associates, Practicing Company Secretary, Mumbai for the half year ended March 31, 2021. Kindly take the same on your record.
14-04-2021
Bigul

Gufic Biosciences Ltd - 509079 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ami N ShahDesignation :- Company Secretary and Compliance Officer
09-04-2021
Bigul

Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the letter received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited for the quarter ended March 31, 2021.
09-04-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliance Certificate For The Half Year Ended March 31, 2021

As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facilities are maintained during the period October 01, 2020 to March 31, 2021 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited.
09-04-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed herewith information regarding loss of share certificates received by us from our Registrar And Share Transfer Agent M/s. Link Intime India Pvt. Ltd. ('RTA') under Regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements Regulations), 2015.
06-04-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Appointment Of Secretarial Auditor For Financial Year 2020-21

Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e Wednesday, March 31, 2021, appointed M/s. Manish Ghia & Associates, Practicing Company Secretaries as the Secretarial Auditor of the Company for the Financial year 2020 -21. A brief profile of M/s. Manish Ghia & Associates, Practicing Company Secretaries, is enclosed herewith, for your reference.
31-03-2021
Next Page
Close

Let's Open Free Demat Account